NCT04526795 2024-12-12Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory LeukemiaM.D. Anderson Cancer CenterPhase 1 Terminated19 enrolled
NCT01849276 2019-01-31Metformin+Cytarabine for the Treatment of Relapsed/Refractory AMLNorthwestern UniversityPhase 1 Terminated2 enrolled 9 charts
NCT00281879 2017-09-27Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic CancerOHSU Knight Cancer InstitutePhase 2 Terminated200 enrolled 11 charts
NCT00023920 2013-01-23Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous LeukemiaNational Cancer Institute (NCI)Phase 2 Terminated60 enrolled